Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Sporadic amyotrophic lateral sclerosis is a amyotrophic lateral sclerosis in which there is no known cause, such as no family history.
Biomarker and diagnostic research for sporadic amyotrophic lateral sclerosis has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
65 publications have been identified in PubMed for sporadic amyotrophic lateral sclerosis. Research spans Basic Science / Preclinical (45%), Epidemiology / Natural History (20%), and Diagnostic / Biomarker (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 29 | 45% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Disease patterns and progression |
13 |
20% |
Testing and diagnosis research | 7 | 11% |
Research summaries | 7 | 11% |
New treatment approaches | 3 | 5% |
Other research | 2 | 3% |
Patient case studies | 2 | 3% |
Clinical study results | 2 | 3% |
Mori F (2026). [PMID: 41926608](https://pubmed.ncbi.nlm.nih.gov/41926608/). *J Neuropathol Exp Neurol*. [Basic Science / Preclinical]
Wang HF (2026). [PMID: 41821328](https://pubmed.ncbi.nlm.nih.gov/41821328/). *Biomed Environ Sci*. [Epidemiology / Natural History]
Sun QH (2026). [PMID: 42205021](https://pubmed.ncbi.nlm.nih.gov/42205021/). *Biomed Environ Sci*. [Epidemiology / Natural History]
Ma M (2026). [PMID: 42269975](https://pubmed.ncbi.nlm.nih.gov/42269975/). *Neurobiol Dis*. [Epidemiology / Natural History]
García-Casanova PH (2026). [PMID: 40824756](https://pubmed.ncbi.nlm.nih.gov/40824756/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Case Report / Case Series]
Li M (2026). [PMID: 41996956](https://pubmed.ncbi.nlm.nih.gov/41996956/). *Sleep Med*. [Diagnostic / Biomarker]
Xu W (2026). [PMID: 42127907](https://pubmed.ncbi.nlm.nih.gov/42127907/). *Mol Cell*. [Basic Science / Preclinical]
Zheng W (2026). [PMID: 41673790](https://pubmed.ncbi.nlm.nih.gov/41673790/). *Neural Regen Res*. [Epidemiology / Natural History]
Komori S (2026). [PMID: 41649950](https://pubmed.ncbi.nlm.nih.gov/41649950/). *J Neuromuscul Dis*. [Epidemiology / Natural History]
Garcia-Delgado AB (2026). [PMID: 41420983](https://pubmed.ncbi.nlm.nih.gov/41420983/). *Stem Cell Res*. [Basic Science / Preclinical]